Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,300.00
-50.00 (-1.15%)
May 15, 2026, 1:00 PM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 88.58 billion as of May 14, 2026. Its market cap has decreased by -7.55% in one year.
Market Cap
88.58B
Enterprise Value
108.27B
Revenue
175.50B
Ranking
n/a
PE Ratio
15.54
Stock Price
4,300.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 88.58B, an increase of 198.83%. That is a compound annual growth rate of 5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 86.54B | -1.16% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dongwha Pharm.Co.,Ltd | 162.43B |
| Kyongbo Pharmaceutical | 152.29B |
| Ilsung Is | 146.35B |
| Jeil Pharma Holdings | 130.48B |
| HANDOK | 123.67B |
| CKD Bio | 103.14B |
| Ildong Holdings | 97.00B |
| Enzychem Lifesciences | 76.86B |